SCHEMBL6136939

SCHEMBL6136939

COc1ccc(C(=O)CCl)cc1Cl

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 7/20 0.53
TAS1R1 Q7RTX1 7/20 0.53
PDE4D Q08499 1/20 0.51
MAPT P10636 3/20 0.49
POLB P06746 1/20 0.49
GSK3B P49841 1/20 0.48
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
ALDH1A1 P00352 2/20 0.48
HTT P42858 1/20 0.48
KCNH2 Q12809 1/20 0.48
TP53 P04637 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
ALOX15 P16050 1/20 0.48
CYP2C19 P33261 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6329414 0.86 TAS1R3 (0.53) TAS1R3TAS1R1PDE4DMAPTPOLB
SCHEMBL12780432 0.86 MEN1 (0.59) TAS1R3TAS1R1PDE4DMAPTPOLB
SCHEMBL4713028 0.86 TSHR (0.63) PDE4DMAPTKMT2AMEN1SMN1; SMN2
SCHEMBL2166529 0.85 GSK3B (0.54) TAS1R3TAS1R1PDE4DMAPTPOLB
SCHEMBL22570710 0.85 TAS1R3 (0.51) TAS1R3TAS1R1PDE4DMAPTPOLB
SCHEMBL29620782 0.85 GSK3B (0.54) TAS1R3TAS1R1PDE4DMAPTPOLB
SCHEMBL9155650 0.85 PDE4D (0.54) TAS1R3TAS1R1PDE4DMAPTPOLB
SCHEMBL22570670 0.84 TAS1R3 (0.49) TAS1R3TAS1R1PDE4DMAPTPOLB
Hydrochloric Acid SCHEMBL29393777 0.83 TAS1R3 (0.50) TAS1R3TAS1R1PDE4DMAPTPOLB
SCHEMBL3950960 0.83 TAS1R3 (0.57) TAS1R3TAS1R1PDE4DMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111004107-B Substituted dichlorobenzene compound containing propenone, preparation method and application 山东大学 2021-03-16 CN disclosed
CN-111004107-A Substituted dichlorobenzene compound containing propenone, preparation method and application 山东大学 2020-04-14 CN disclosed
EP-1011651-B1 METHOD OF TREATING DIABETES AND RELATED DISEASE STATES MERCK & CO INC (US) 2005-04-27 EP disclosed
EP-1011651-A4 METHOD OF TREATING DIABETES AND RELATED DISEASE STATES MERCK & CO INC (US) 2000-06-28 EP disclosed
EP-1011651-A1 METHOD OF TREATING DIABETES AND RELATED DISEASE STATES Merck & Co., Inc. (US) 2000-06-28 EP disclosed
US-6020382-A Method of treating diabetes and related disease states MERCK & CO., INC. (US) 2000-02-01 US disclosed
US-5847008-A Method of treating diabetes and related disease states MERCK & CO., INC. (US) 1998-12-08 US disclosed
WO-1997027847-A1 METHOD OF TREATING DIABETES AND RELATED DISEASE STATES MERCK & CO., INC. (US) 1997-08-07 WO disclosed
US-5466717-A INHIBITING THE GROWTH OF MICROORGANISMS IN AN AQUEOUS SYSTEM BUCKMAN LABORATORIES INT'L, INC. (US) 1995-11-14 US disclosed
EP-0639049-A1 HALOGENATED 4'-METHOXYACETOPHENONES AS MICROBICIDES AND PRESERVATIVES BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 1995-02-22 EP disclosed
WO-1993022918-A1 HALOGENATED 4'-METHOXYACETOPHENONES AS MICROBICIDES AND PRESERVATIVES BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) 1993-11-25 WO disclosed
EP-0106565-B1 LEUKOTRIENE ANTAGONISTS, THEIR PRODUCTION, AND COMPOSITIONS CONTAINING THEM MERCK FROSST CANADA INC. (CA) 1986-09-10 EP disclosed
EP-0106565-A1 Leukotriene antagonists, their production, and compositions containing them MERCK FROSST CANADA INC. (CA) 1984-04-25 EP disclosed